Study
Mushroom Supplements May Support Brain Health in Seniors with Mild Alzheimer's
Taking Lion's Mane mushroom supplements daily might improve cognitive function in older adults with mild Alzheimer's disease.
Brain HealthHealthy AgingMemory SupportSupplement
Summary
In plain language
Recent research suggests that daily supplements of the Lion's Mane mushroom could help improve cognitive function in seniors with mild Alzheimer's disease. The study involved 68 participants over the age of 50 who were diagnosed with mild Alzheimer's. Those who took three capsules of Lion's Mane mushroom daily for a year showed improvements in cognitive assessments compared to those who took a placebo. This finding is encouraging as it highlights a potential natural approach to support brain health in the early stages of Alzheimer's. Seniors interested in trying this supplement should discuss it with their healthcare providers to ensure it's appropriate for their individual health needs.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was a year-long, randomized trial involving 68 seniors with mild Alzheimer's disease. Participants were divided into two groups: one received daily Lion's Mane mushroom supplements, and the other received a placebo. Cognitive function was assessed at various intervals, showing improvement in the group taking the mushroom supplement.
The study was carefully designed to eliminate bias, with participants unaware of which group they were in.
Results indicated a positive impact on cognitive abilities, suggesting the mushroom's potential for aiding brain health.
However, as a pilot study, more research is needed to confirm these results and understand possible side effects.
Seniors should consult their doctors before starting new supplements to ensure compatibility with existing treatments.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Mushroom Supplements May Support Brain Health in Seniors with Mild Alzheimer's
Published May 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Assessment
The study is a high-quality randomized controlled trial with strong design and bias control, making it a reliable source of evidence for the effects of mushroom supplements on brain health in seniors with mild Alzheimer's. However, the lack of replication and the mid-tier journal publication slightly limit its impact.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 10.0/10 | |
| Bias & Methods | 10.0/10 | |
| Statistical Integrity | 10.0/10 | |
| Transparency | 10.0/10 | |
| Conflict of Interest Disclosure | 7.5/10 | |
| Replication / External Validation | 0.0/10 | |
| Relevance to Seniors | 10.0/10 | |
| Journal Quality | 5.0/10 |
Additional Notes
The study's focus on a senior population with Alzheimer's is particularly relevant, but further replication studies would strengthen the findings.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.